Frank W. Oertel
Direktor/Vorstandsmitglied bei BioAgency AG
Profil
Frank W.
Oertel is the founder of Indivumed GmbH, which was founded in 2002.
Currently, he holds the position of Member-Supervisory Board at BioAgency AG.
Aktive Positionen von Frank W. Oertel
| Unternehmen | Position | Beginn |
|---|---|---|
BioAgency AG
 BioAgency AG Financial ConglomeratesFinance BioAgency AG provides financing services. The company is headquartered in Hamburg, Germany. | Direktor/Vorstandsmitglied | - |
Ehemalige bekannte Positionen von Frank W. Oertel
| Unternehmen | Position | Ende |
|---|---|---|
Indivumed GmbH
 Indivumed GmbH Data Processing ServicesTechnology Services Indivumed GmbH engages in the research and development of medical treatment for cancer patients. The firm develops an integrated analytical platform, which links sample sets from cancer patients such as tissue types, serum, plasma, and urine with a web-accessible database. It offers treatment for the people suffering from GI-tract such as colorectal, gastric, pancreatic, breast, and lung cancer. The company was founded by Hartmut Juhl, Carsten Zornig and Peter Layer in April 2002 and is headquartered in Hamburg, Germany. | Gründer | - |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Private Unternehmen | 2 |
|---|---|
BioAgency AG
BioAgency AG Financial ConglomeratesFinance BioAgency AG provides financing services. The company is headquartered in Hamburg, Germany. | Finance |
Indivumed GmbH
Indivumed GmbH Data Processing ServicesTechnology Services Indivumed GmbH engages in the research and development of medical treatment for cancer patients. The firm develops an integrated analytical platform, which links sample sets from cancer patients such as tissue types, serum, plasma, and urine with a web-accessible database. It offers treatment for the people suffering from GI-tract such as colorectal, gastric, pancreatic, breast, and lung cancer. The company was founded by Hartmut Juhl, Carsten Zornig and Peter Layer in April 2002 and is headquartered in Hamburg, Germany. | Technology Services |
